✦ LIBER ✦

Combination therapy with radiation and mitomycin C: Preliminary results with EMT6 tumor cells in vitro and in vivo

✍ Scribed by Sara Rockwell; Katherine A Kennedy

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 423 KB
Volume: 5
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(79)90795-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with radiation, mito

Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors

✍ Sara Rockwell 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 913 KB

Combination therapy with misonidazole an

Combination therapy with misonidazole and mitomycin C: Lack of chemosensitization of EMT6 tumor cells in vivo or in vitro

✍ Sara Rockwell 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Enhancement of EMT6/SF tumor cell killin

Enhancement of EMT6/SF tumor cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine

✍ Koji Ono; Dennis C. Shrieve 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Preliminary trial of combination therapy

Preliminary trial of combination therapy with adriamycin and radiation in sarcomas and other malignant tumors

✍ Peter P. Sordillo; Gordon B. Magill; Peter K. Schauer; Bhadrasain Vikram; Jae H. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

## Abstract Based on reports of synergism between adriamycin and radiation therapy in experimental systems, a trial was initiated testing this combination in 53 adult patients with various advanced malignancies, especially sarcomas. Since studies have suggested a selective sensitization of hypoxic

Interaction of interleukin-11 with cytot

Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma

✍ Beverly A. Teicher; Ying-nan Chen; Gulshan Ara; Yasunori Emi; Yoshihiro Kakeji; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 687 KB

## Interleukin -I I (rhlL-I I) is a cytokine that has been shown to enhance the recovery of bone marrow and intestinal crypt cells after cytotoxic insult with radiation or anticancer drugs. The current study examined the effects of rhlL-I I on the response of CEM human lymphoblastic leukemia cells

Combination therapy with mitomycin C, 5-

Combination therapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside for nonresectable malignant tumor in man

✍ Takayuki Yamaguchi; Masanori Nakamura 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effectiveness of MFC (mitomycin C, 5-fluorouracil and cytosine arabinoside) therapy for nonresectable cancers and cancers recurring after surgery was investigated in 60 patients with solid cancers aged 26 to 69 years. Treatment was effective in 28 patients (47%) including seven (12%) who showed